We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSBC icon
401
HSBC
HSBC
$355B
$723K 0.04%
18,257
-7,157
-28% -$267K
TTE icon
402
TotalEnergies
TTE
$193B
$720K 0.04%
12,491
-2,391
-16% -$145K
RETA
403
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$714K 0.04%
7,007
+2,401
+52% +$227K
CMS icon
404
CMS Energy
CMS
$23.1B
$713K 0.04%
12,141
-1,087
-8% -$65.6K
PSA icon
405
Public Storage
PSA
$60.2B
$712K 0.04%
2,440
-42
-2% -$12.2K
NEX
406
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$710K 0.04%
79,473
+1,607
+2% +$13.3K
ATO icon
407
Atmos Energy
ATO
$29.9B
$705K 0.04%
6,057
-491
-7% -$56.8K
NE icon
408
Noble Corp
NE
$6.9B
$698K 0.04%
16,903
+125
+0.7% +$4.81K
ASX icon
409
ASE Group
ASX
$80.8B
$697K 0.04%
89,483
+1,786
+2% +$13.7K
ITCI
410
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$696K 0.04%
10,997
-271
-2% -$16.9K
APTV icon
411
Aptiv
APTV
$12B
$695K 0.04%
6,807
+2,253
+49% +$223K
WFRD icon
412
Weatherford International
WFRD
$6.36B
$695K 0.04%
10,461
-1,011
-9% -$62.3K
USB icon
413
US Bancorp
USB
$99.6B
$694K 0.04%
21,001
-576
-3% -$18.6K
ENTG icon
414
Entegris
ENTG
$19.7B
$684K 0.04%
6,174
+807
+15% +$73.6K
SMAR
415
DELISTED
Smartsheet Inc.
SMAR
$683K 0.04%
17,864
+1,131
+7% +$48.9K
ALLO icon
416
Allogene Therapeutics
ALLO
$601M
$682K 0.04%
137,232
+12,621
+10% +$68.3K
EDU icon
417
New Oriental
EDU
$7.84B
$675K 0.04%
17,090
-1,275
-7% -$51K
WHD icon
418
Cactus
WHD
$3.83B
$674K 0.04%
15,931
+546
+4% +$21.3K
APA icon
419
APA Corp
APA
$12.8B
$673K 0.04%
19,682
-2,985
-13% -$104K
ELAN icon
420
Elanco Animal Health
ELAN
$12.4B
$670K 0.04%
66,643
+6,224
+10% +$57.8K
FDX icon
421
FedEx
FDX
$74.5B
$667K 0.04%
2,691
+212
+9% +$48.5K
MCRB icon
422
Seres Therapeutics
MCRB
$48M
$667K 0.04%
6,962
+4,719
+210% +$514K
BILI icon
423
Bilibili
BILI
$7.18B
$665K 0.04%
44,024
-4,872
-10% -$89.4K
RIG icon
424
Transocean
RIG
$5.92B
$663K 0.04%
94,587
+4,234
+5% +$26.2K
PRGO icon
425
Perrigo
PRGO
$1.4B
$662K 0.04%
19,502
-1,208
-6% -$42K

Similar funds

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.